FDA On Physician Comments Concerning Unapproved Drugs

The FDA has sent a letter to dermatologist and researcher Leslie Baumann about comments she made to the media concerning a drug before its approval. The FDA noted that Dr. Baumann was “an investigator on a clinical trial for Dysport and promoted it well before the drug’s approval in April.” Read more in a New York Times article.